Simultaneous quantification of zidovudine and its glucuronide in serum by high-performance liquid chromatography (Q68048909)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3235523%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

title

Simultaneous quantification of zidovudine and its glucuronide in serum by high-performance liquid chromatography (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3235523%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

0 references

1 reference

high-performance liquid chromatography

1 reference

S S Good

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3235523%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

D J Reynolds

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3235523%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

P de Miranda

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3235523%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

publication date

1 September 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3235523%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

volume

431

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3235523%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3235523%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

page(s)

123-133

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3235523%20AND%20SRC:MED&resulttype=core&format=json

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

21 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983075-3

7 January 2021

Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983075-3

7 January 2021

Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983075-3

7 January 2021

Significant changes in HIV antigen level in the serum of patients treated with azidothymidine.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983075-3

7 January 2021

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983075-3

7 January 2021

Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983075-3

7 January 2021

Plasma and cerebrospinal fluid pharmacokinetics of 3'-azido-3'-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983075-3

7 January 2021

Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2983075-3

7 January 2021

10.1016/S0378-4347(00)83075-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3235523%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

1 reference